← Back to headlines
BofA Raises Price Target on Teva Pharmaceutical (TEVA)
Bank of America has raised its price target for Teva Pharmaceutical (TEVA) stock to $42.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
South Korean Survey Reveals Widespread Poor Sleep Quality and Insufficient Sleep Duration
19m ago
Katsina State Unveils Nutrition Centres, Warns Against Food Diversion
36m ago
New Zealand Prepares for 'Super-K' Flu Strain Ahead of Winter
50m ago
How to Get Rid of Pimples on Cheeks? Dermatologist Jenna Huld Eysteinsdóttir Has the Answer
1h ago